Income Statement Indutrade AB

Equities

INDT

SE0001515552

Industrial Machinery & Equipment

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2026-04-15 EDT			5-day change	1st Jan Change
227.00 ^SEK	+0.53%		+3.56%	-5.57%

09:54am	Indutrade Buys Wound Care Products Company Axotan	MT
08:05am	Indutrade acquires Axotan - annual revenue of approximately SEK 50 million	FW

73bf.473z3i0Jh3rpOJC7JkIw20StVIctuV-Kf5ldtgd_J1Q.memUrXRx4hioFfjQFSVCoQzkLqp34DvdSu9t_jY7UjC6kJi6VGT9L5h1_w

Published financial data: INDUTRADE AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	21.72B	27.02B	31.84B	32.54B	32.23B
Total Revenues	21.72B	27.02B	31.84B	32.54B	32.23B
Cost of Goods Sold, Total	14.11B	17.65B	20.79B	21.14B	20.82B
Gross Profit	7.61B	9.36B	11.05B	11.4B	11.4B
Selling General & Admin Expenses, Total	4.51B	5.54B	6.58B	7.12B	7.25B
R&D Expenses	258M	334M	395M	406M	378M
Other Operating Expenses	-2M	-16M	-1M	-3M	0
Other Operating Expenses, Total	4.77B	5.86B	6.98B	7.52B	7.62B
Operating Income	2.84B	3.51B	4.07B	3.88B	3.78B
Interest Expense, Total	-101M	-198M	-501M	-566M	-436M
Interest And Investment Income	15M	38M	63M	100M	63M
Net Interest Expenses	-86M	-160M	-438M	-466M	-373M
Currency Exchange Gains (Loss)	9M	53M	10M	9M	-41M
Other Non Operating Income (Expenses)	-25M	-23M	-30M	-26M	-34M
EBT, Excl. Unusual Items	2.74B	3.38B	3.61B	3.4B	3.33B
Merger & Related Restructuring Charges	-21M	-15M	-15M	-18M	-24M
Impairment of Goodwill	-55M	-72M	-351M	-15M	-154M
Gain (Loss) On Sale Of Assets	-2M	10M	-	-5M	-26M
Asset Writedown	-5M	-	-69M	-12M	-
Insurance Settlements	8M	3M	19M	9M	11M
Other Unusual Items	62M	138M	495M	168M	193M
EBT, Incl. Unusual Items	2.72B	3.44B	3.69B	3.53B	3.33B
Income Tax Expense	628M	759M	825M	777M	770M
Earnings From Continuing Operations	2.1B	2.68B	2.87B	2.75B	2.56B
Net Income to Company	2.1B	2.68B	2.87B	2.75B	2.56B
Minority Interest	-2M	1M	-1M	-1M	-2M
Net Income - (IS)	2.1B	2.68B	2.86B	2.75B	2.56B
Net Income to Common Incl Extra Items	2.1B	2.68B	2.86B	2.75B	2.56B
Net Income to Common Excl. Extra Items	2.1B	2.68B	2.86B	2.75B	2.56B
Per Share Items
Net EPS - Basic	5.76	7.36	7.86	7.55	7.03
Basic EPS - Continuing Operations	5.76	7.36	7.86	7.55	7.03
Basic Weighted Average Shares Outstanding	364M	364M	364M	364M	364M
Net EPS - Diluted	5.75	7.36	7.86	7.54	7.03
Diluted EPS - Continuing Operations	5.75	7.36	7.86	7.54	7.03
Diluted Weighted Average Shares Outstanding	364M	364M	364M	364M	364M
Normalized Basic EPS	4.7	5.8	6.19	5.83	5.71
Normalized Diluted EPS	4.69	5.79	6.19	5.83	5.71
Dividend Per Share	2.3	2.6	2.85	3	3.1
Payout Ratio	31.26	31.21	33.02	37.69	42.62
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	3.52B	4.33B	5.11B	4.98B	4.9B
EBITA	3.24B	4.01B	4.7B	4.56B	4.47B
EBIT	2.84B	3.51B	4.07B	3.88B	3.78B
EBITDAR	3.54B	4.36B	5.14B	5.01B	4.93B
Effective Tax Rate - (Ratio)	23.05	22.06	22.35	22.03	23.11
Total Current Taxes	662M	798M	942M	960M	930M
Total Deferred Taxes	-36M	-41M	-122M	-185M	-172M
Normalized Net Income	1.71B	2.11B	2.26B	2.12B	2.08B
Interest on Long-Term Debt	32M	36M	56M	91M	93M
Non-Cash Pension Expense	3M	3M	5M	6M	6M
Supplemental Operating Expense Items
Marketing Expenses	135M	217M	255M	282M	266M
Selling and Marketing Expenses	3.28B	3.98B	4.62B	5B	5.11B
General and Administrative Expenses	1.23B	1.56B	1.96B	2.11B	2.13B
Research And Development Expense From Footnotes	258M	334M	395M	406M	378M
Net Rental Expense, Total	22M	24M	28M	30M	32M
Imputed Operating Lease Interest Expense	3M	4.6M	11.01M	12.69M	10.84M
Imputed Operating Lease Depreciation	19M	19.4M	16.99M	17.31M	21.16M
Stock-Based Comp., Other (Total)	-	32M	43M	53M	-18M
Total Stock-Based Compensation	-	32M	43M	53M	-18M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.46B	1.59B	3.01B	3.05B	2.39B
Total Cash And Short Term Investments	1.46B	1.59B	3.01B	3.05B	2.39B
Accounts Receivable, Total	3.62B	4.68B	4.81B	5.26B	5.06B
Other Receivables	334M	449M	567M	709M	822M
Total Receivables	3.96B	5.13B	5.38B	5.96B	5.88B
Inventory	4.07B	5.68B	5.42B	5.5B	5.1B
Prepaid Expenses	147M	181M	209M	230M	246M
Other Current Assets, Total	8M	15M	18M	25M	17M
Total Current Assets	9.64B	12.6B	14.04B	14.78B	13.64B
Gross Property Plant And Equipment	7.47B	9.3B	10.28B	11.41B	11.48B
Accumulated Depreciation	-4.09B	-5.25B	-5.88B	-6.71B	-7B
Net Property Plant And Equipment	3.38B	4.04B	4.4B	4.7B	4.49B
Long-term Investments	-	-	-	-	-
Goodwill	5.44B	7.65B	8.27B	9.72B	9.93B
Other Intangibles, Total	3.33B	4.41B	4.35B	4.99B	4.91B
Deferred Tax Assets Long-Term	-	-	-	-	182M
Other Long-Term Assets, Total	204M	160M	208M	243M	82M
Total Assets	22B	28.86B	31.28B	34.42B	33.23B
Liabilities
Accounts Payable, Total	1.6B	1.87B	1.77B	2B	1.82B
Accrued Expenses, Total	986M	1.16B	1.2B	1.2B	1.2B
Short-term Borrowings	151M	336M	48M	27M	7M
Current Portion of Long-Term Debt	914M	1.5B	1.85B	1.87B	1.65B
Current Portion of Leases	348M	432M	476M	554M	540M
Current Income Taxes Payable	284M	419M	383M	382M	364M
Unearned Revenue Current, Total	207M	331M	435M	532M	352M
Other Current Liabilities	698M	837M	916M	929M	950M
Total Current Liabilities	5.18B	6.89B	7.07B	7.49B	6.89B
Long-Term Debt	4.44B	6.82B	7.08B	7.41B	6.44B
Long-Term Leases	751M	838M	1B	1.09B	1.01B
Pension & Other Post Retirement Benefits	350M	243M	299M	312M	305M
Deferred Tax Liability Non Current	953M	1.28B	1.31B	1.43B	1.43B
Other Non Current Liabilities	23M	21M	24M	34M	37M
Total Liabilities	11.7B	16.09B	16.79B	17.77B	16.11B
Common Stock, Total	728M	729M	729M	729M	729M
Retained Earnings	9.24B	11.19B	13.05B	14.76B	16.21B
Comprehensive Income and Other	325M	844M	693M	1.15B	172M
Total Common Equity	10.29B	12.76B	14.48B	16.64B	17.11B
Minority Interest	11M	14M	14M	11M	5M
Total Equity	10.3B	12.77B	14.49B	16.65B	17.12B
Total Liabilities And Equity	22B	28.86B	31.28B	34.42B	33.23B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	364M	364M	364M	364M	364M
ECS Total Common Shares Outstanding	364M	364M	364M	364M	364M
Book Value / Share	28.26	35.02	39.73	45.68	46.97
Tangible Book Value	1.52B	702M	1.85B	1.94B	2.27B
Tangible Book Value Per Share	4.18	1.93	5.08	5.32	6.23
Total Debt	6.6B	9.93B	10.46B	10.95B	9.64B
Net Debt	5.14B	8.34B	7.45B	7.89B	7.25B
Debt Equivalent of Unfunded Proj. Benefit Obligation	285M	169M	217M	222M	209M
Debt Equivalent Oper. Leases	176M	192M	224M	240M	256M
Minority Interest, Total (Incl. Fin. Div)	11M	14M	14M	11M	5M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	956M	1.36B	1.36B	1.36B	1.35B
Inventories - Work In Process, Total	333M	459M	431M	485M	370M
Inventories - Finished Goods, Total	2.72B	3.79B	3.58B	3.56B	3.31B
Land - (BS)	1.91B	2.27B	2.38B	2.55B	2.53B
Machinery, Total	3.61B	4.54B	4.91B	5.45B	5.58B
Full Time Employees	8.18K	9.13K	9.3K	9.7K	9.85K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	67M	112M	115M	131M	126M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	2.1B	2.68B	2.86B	2.75B	2.56B
Depreciation & Amortization - CF	639M	734M	906M	980M	1B
Amortization of Goodwill and Intangible Assets - (CF)	399M	502M	633M	678M	692M
Depreciation & Amortization, Total	1.04B	1.24B	1.54B	1.66B	1.69B
Amortization of Deferred Charges, Total - (CF)	20M	22M	26M	28M	32M
(Gain) Loss From Sale Of Asset	-8M	66M	443M	29M	-47M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Other Operating Activities, Total	50M	-76M	-581M	-434M	-313M
Change In Accounts Receivable	-149M	-611M	190M	-40M	-38M
Change In Inventories	-374M	-1.01B	417M	283M	257M
Change In Accounts Payable	288M	98M	-183M	73M	-166M
Change in Other Net Operating Assets	-107M	-33M	-225M	-212M	12M
Cash from Operations	2.85B	2.37B	4.49B	4.13B	3.99B
Capital Expenditure	-339M	-511M	-519M	-485M	-502M
Sale of Property, Plant, and Equipment	17M	49M	18M	64M	54M
Cash Acquisitions	-1.67B	-2.83B	-1.58B	-2.08B	-1.76B
Divestitures	7M	2M	-	14M	18M
Sale (Purchase) of Intangible assets	-35M	-36M	-41M	-36M	-42M
Investment in Marketable and Equity Securities, Total	17M	7M	-10M	18M	4M
Cash from Investing	-2B	-3.32B	-2.13B	-2.5B	-2.23B
Long-Term Debt Issued, Total	4.3B	3.95B	2.62B	1.98B	2.2B
Total Debt Issued	4.3B	3.95B	2.62B	1.98B	2.2B
Long-Term Debt Repaid, Total	-3.9B	-2.13B	-2.6B	-2.57B	-3.45B
Total Debt Repaid	-3.9B	-2.13B	-2.6B	-2.57B	-3.45B
Issuance of Common Stock	48M	11M	-	-	-
Common Dividends Paid	-655M	-837M	-946M	-1.04B	-1.09B
Common & Preferred Stock Dividends Paid	-655M	-837M	-946M	-1.04B	-1.09B
Other Financing Activities, Total	-	-	-	-6M	-1M
Cash from Financing	-200M	991M	-932M	-1.63B	-2.34B
Foreign Exchange Rate Adjustments	49M	83M	-8M	42M	-81M
Net Change in Cash	702M	129M	1.42B	42M	-661M
Supplemental Items
Cash Interest Paid	84M	160M	421M	519M	447M
Cash Income Tax Paid (Refund)	638M	764M	1.05B	1.12B	1.1B
Levered Free Cash Flow	1.94B	828M	3.33B	2.94B	3.39B
Unlevered Free Cash Flow	2B	952M	3.65B	3.3B	3.66B
Change In Net Working Capital	460M	1.98B	-55M	349M	-133M
Net Debt Issued / Repaid	407M	1.82B	14M	-590M	-1.24B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.88	8.62	8.46	7.39	6.98
Return on Total Capital	11.54	11.07	10.68	9.24	8.69
Return On Equity %	22.15	23.24	21.03	17.66	15.17
Return on Common Equity	22.15	23.27	21.04	17.67	15.17
Margin Analysis
Gross Profit Margin %	35.04	34.65	34.7	35.04	35.38
SG&A Margin	20.78	20.5	20.68	21.87	22.48
EBITDA Margin %	16.22	16.04	16.04	15.31	15.19
EBITA Margin %	14.92	14.84	14.77	14.01	13.88
EBIT Margin %	13.08	12.98	12.78	11.93	11.73
Income From Continuing Operations Margin %	9.66	9.92	9	8.45	7.95
Net Income Margin %	9.65	9.93	9	8.45	7.94
Net Avail. For Common Margin %	9.65	9.93	9	8.45	7.94
Normalized Net Income Margin	7.87	7.81	7.09	6.53	6.46
Levered Free Cash Flow Margin	8.91	3.07	10.47	9.04	10.51
Unlevered Free Cash Flow Margin	9.21	3.52	11.46	10.13	11.35
Asset Turnover
Asset Turnover	1.09	1.06	1.06	0.99	0.95
Fixed Assets Turnover	6.69	7.27	7.54	7.16	7.02
Receivables Turnover (Average Receivables)	6.5	6.5	6.7	6.46	6.25
Inventory Turnover (Average Inventory)	3.8	3.62	3.74	3.87	3.93
Short Term Liquidity
Current Ratio	1.86	1.83	1.99	1.97	1.98
Quick Ratio	1.04	0.98	1.19	1.2	1.2
Operating Cash Flow to Current Liabilities	0.55	0.34	0.64	0.55	0.58
Days Sales Outstanding (Average Receivables)	56.17	56.12	54.44	56.62	58.43
Days Outstanding Inventory (Average Inventory)	95.93	100.8	97.51	94.62	92.89
Average Days Payable Outstanding	33.64	32.84	32.32	32.45	34.11
Cash Conversion Cycle (Average Days)	118.47	124.08	119.64	118.79	117.21
Long Term Solvency
Total Debt/Equity	64.05	77.71	72.19	65.74	56.34
Total Debt / Total Capital	39.04	43.73	41.93	39.67	36.03
LT Debt/Equity	50.33	59.97	55.8	51.04	43.5
Long-Term Debt / Total Capital	30.68	33.75	32.41	30.79	27.82
Total Liabilities / Total Assets	53.17	55.74	53.67	51.62	48.48
EBIT / Interest Expense	28.12	17.71	8.12	6.86	8.67
EBITDA / Interest Expense	38.4	23.95	11.2	9.79	12.55
(EBITDA - Capex) / Interest Expense	35.04	21.37	10.16	8.93	11.4
Total Debt / EBITDA	1.7	2.09	1.86	1.98	1.76
Net Debt / EBITDA	1.33	1.76	1.33	1.42	1.32
Total Debt / (EBITDA - Capex)	1.86	2.35	2.06	2.17	1.94
Net Debt / (EBITDA - Capex)	1.45	1.97	1.46	1.56	1.46
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13	24.41	17.84	2.23	-0.97
Gross Profit, 1 Yr. Growth %	16.42	23.04	17.99	3.24	0
EBITDA, 1 Yr. Growth %	25.82	23.02	17.84	-2.47	-1.71
EBITA, 1 Yr. Growth %	27.37	23.74	17.34	-3.04	-1.95
EBIT, 1 Yr. Growth %	30.51	23.45	16.09	-4.62	-2.65
Earnings From Cont. Operations, 1 Yr. Growth %	25.64	27.85	6.9	-4.05	-6.84
Net Income, 1 Yr. Growth %	25.52	28.02	6.82	-4.05	-6.88
Normalized Net Income, 1 Yr. Growth %	33.93	23.5	6.89	-6.21	-2.05
Diluted EPS Before Extra, 1 Yr. Growth %	25.27	28	6.79	-4.07	-6.81
Accounts Receivable, 1 Yr. Growth %	18.43	29.22	2.8	9.18	-3.69
Inventory, 1 Yr. Growth %	21.54	39.7	-4.54	1.47	-7.45
Net Property, Plant and Equip., 1 Yr. Growth %	8.98	19.5	8.73	6.75	-4.43
Total Assets, 1 Yr. Growth %	22.48	31.19	8.36	10.06	-3.46
Tangible Book Value, 1 Yr. Growth %	-6.34	-53.88	163.53	4.76	17.18
Common Equity, 1 Yr. Growth %	19.34	23.97	13.45	14.97	2.84
Cash From Operations, 1 Yr. Growth %	2.63	-16.86	89.33	-7.95	-3.48
Capital Expenditures, 1 Yr. Growth %	-13.08	50.74	1.57	-6.55	3.51
Levered Free Cash Flow, 1 Yr. Growth %	-5.42	-57.49	314.56	-11.04	16.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-5.4	-52.67	293.01	-8.77	12.46
Dividend Per Share, 1 Yr. Growth %	27.78	13.04	9.62	5.26	3.33
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.6	18.57	21.08	9.76	0.62
Gross Profit, 2 Yr. CAGR %	10.03	19.68	20.49	10.37	1.61
EBITDA, 2 Yr. CAGR %	18.07	24.41	20.4	7.22	-2.09
EBITA, 2 Yr. CAGR %	18.83	25.54	20.5	6.68	-2.5
EBIT, 2 Yr. CAGR %	20.04	26.93	19.71	5.24	-3.64
Earnings From Cont. Operations, 2 Yr. CAGR %	18.91	26.74	16.91	1.28	-5.45
Net Income, 2 Yr. CAGR %	18.9	26.77	16.94	1.24	-5.47
Normalized Net Income, 2 Yr. CAGR %	21.47	28.61	14.9	0.31	-4.15
Diluted EPS Before Extra, 2 Yr. CAGR %	18.6	26.63	16.92	1.22	-5.45
Accounts Receivable, 2 Yr. CAGR %	7.52	23.71	15.25	5.94	2.54
Inventory, 2 Yr. CAGR %	8.48	30.3	15.48	-1.58	-3.09
Net Property, Plant and Equip., 2 Yr. CAGR %	6.19	14.12	13.99	7.74	1.01
Total Assets, 2 Yr. CAGR %	11.98	26.76	19.23	9.21	3.07
Tangible Book Value, 2 Yr. CAGR %	83.1	-34.27	10.25	66.15	10.8
Common Equity, 2 Yr. CAGR %	19.92	21.63	18.59	14.21	8.73
Cash From Operations, 2 Yr. CAGR %	21.84	-7.63	25.46	32.02	-5.74
Capital Expenditures, 2 Yr. CAGR %	-6.29	14.47	23.73	-2.58	-1.65
Levered Free Cash Flow, 2 Yr. CAGR %	37.95	-36.38	30.79	91.28	1.18
Unlevered Free Cash Flow, 2 Yr. CAGR %	35.56	-32.87	34.63	88.47	0.63
Dividend Per Share, 2 Yr. CAGR %	-	20.18	11.32	7.42	4.29
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.83	13.64	18.32	14.44	6.06
Gross Profit, 3 Yr. CAGR %	9.79	14.21	19.11	14.44	6.8
EBITDA, 3 Yr. CAGR %	15.26	19.7	22.18	12.24	4.16
EBITA, 3 Yr. CAGR %	16.06	20.44	22.75	12.09	3.72
EBIT, 3 Yr. CAGR %	16.44	21.16	23.21	10.99	2.54
Earnings From Cont. Operations, 3 Yr. CAGR %	15.3	21.82	19.75	9.46	-1.5
Net Income, 3 Yr. CAGR %	15.29	21.86	19.74	9.48	-1.54
Normalized Net Income, 3 Yr. CAGR %	16.75	22.15	20.92	7.51	-0.48
Diluted EPS Before Extra, 3 Yr. CAGR %	15.11	21.66	19.64	9.45	-1.53
Accounts Receivable, 3 Yr. CAGR %	6.79	14.31	16.3	13.19	2.63
Inventory, 3 Yr. CAGR %	12.14	18.02	17.47	10.61	-3.58
Net Property, Plant and Equip., 3 Yr. CAGR %	24.93	10.45	12.29	11.52	3.52
Total Assets, 3 Yr. CAGR %	16.07	18.05	20.31	16.09	4.81
Tangible Book Value, 3 Yr. CAGR %	20.68	15.64	4.42	8.39	47.9
Common Equity, 3 Yr. CAGR %	18.37	21.25	18.84	17.37	10.28
Cash From Operations, 3 Yr. CAGR %	28.01	7.26	17.34	13.16	18.93
Capital Expenditures, 3 Yr. CAGR %	5.1	9.8	9.99	12.68	-0.59
Levered Free Cash Flow, 3 Yr. CAGR %	42.88	-6.61	17.66	14.72	61.48
Unlevered Free Cash Flow, 3 Yr. CAGR %	41.38	-4.34	19.95	17.88	57.98
Dividend Per Share, 3 Yr. CAGR %	15.31	-	16.55	9.26	6.04
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.88	12.72	13.57	12.07	10.9
Gross Profit, 5 Yr. CAGR %	11.84	13.52	13.95	12.66	11.78
EBITDA, 5 Yr. CAGR %	16.68	18.27	17.29	14.54	11.83
EBITA, 5 Yr. CAGR %	17.42	19.18	17.81	14.73	11.95
EBIT, 5 Yr. CAGR %	18.16	19.68	17.74	14.52	11.68
Earnings From Cont. Operations, 5 Yr. CAGR %	17.51	21.09	15.94	13.15	8.95
Net Income, 5 Yr. CAGR %	17.48	21.12	15.95	13.15	8.93
Normalized Net Income, 5 Yr. CAGR %	18.51	19.93	16.01	12.89	10.27
Diluted EPS Before Extra, 5 Yr. CAGR %	17.26	20.95	15.83	13.03	8.89
Accounts Receivable, 5 Yr. CAGR %	9.6	12.9	10.1	10.89	10.59
Inventory, 5 Yr. CAGR %	12.58	17.45	13.46	9.75	8.77
Net Property, Plant and Equip., 5 Yr. CAGR %	18.46	20.11	20.43	9.36	7.63
Total Assets, 5 Yr. CAGR %	14.76	18.09	17.32	14.43	13.09
Tangible Book Value, 5 Yr. CAGR %	65.66	28.04	16.39	33.68	6.92
Common Equity, 5 Yr. CAGR %	18.58	19.89	18.46	18.38	14.69
Cash From Operations, 5 Yr. CAGR %	18.77	8.83	26.99	16.55	7.49
Capital Expenditures, 5 Yr. CAGR %	2.07	18.79	12.19	4.67	5.18
Levered Free Cash Flow, 5 Yr. CAGR %	37.94	-2.27	38.1	23.66	10.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	35.81	-0.32	38.82	24.82	11.6
Dividend Per Share, 5 Yr. CAGR %	16.61	15.77	13.7	-	11.49